Results 41 to 50 of about 240 (155)

Niveles de eritropoyetina y reticulocitos en residentes de bajas alturas migrantes a medianas altura

open access: yesRevista de la Universidad Industrial de Santander. Salud, 2017
Introduction: Erythropoietin is a glycosylated alpha globulin with renal production in more than 90% in adult life. It is the main hormone in the constant maintenance of erythrocyte mass, although there are modifications in its levels associated with smoking, anemia, COPD and migration from low to medium or high altitudes. The latter triggers a hypoxic
Manuel Alejandro Peralta González   +2 more
openaire   +3 more sources

Challenges in the care of Ewing’s sarcoma in a Jehovah’s Witness patient [PDF]

open access: yesBiomedica, 2023
Vargas-Potes CJ   +3 more
europepmc   +1 more source

Eritropoyetina como agente eritropoyético y no eritropoyético: consideraciones terapéuticas

open access: yes, 2016
Fil: Nesse, Alcira Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales.
Vittori, Daniela Cecilia   +2 more
openaire   +1 more source

Porfiria cutánea tarda vs pseudoporfiria cutánea tarda en un paciente en hemodiálisis. Presentación de un caso

open access: yesMedisur, 2020
La porfiria cutánea tarda (PCT) es una enfermedad relativamente común. Es el resultado de la deficiencia funcional de una enzima llamada uroporfirinógeno descarboxilasa.
Eliseo Capote Leyva
doaj  

Consensus document on anemia and iron deficiency in heart failure: Consejo Interamericano de Falla Cardiaca e Hipertensión Pulmonar (CIFACAH) of the Interamerican Society of Cardiology (IASC). [PDF]

open access: yesArch Cardiol Mex, 2023
Speranza M   +16 more
europepmc   +1 more source

Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.

open access: yesMedisur, 2010
Recombinant human erythropoietin has been used for more than two decades in clinical practice with promising results in the treatment of anemia associated with chronic renal insufficiency and in patients with cancer.
Rafael Alejandro Gómez Baute   +4 more
doaj   +2 more sources

Hallazgo incidental de una hemoglobina rara: hemoglobina Bari en el noreste de España. [PDF]

open access: yesAdv Lab Med, 2023
Lahoz Alonso R   +10 more
europepmc   +1 more source

[Iron in pre-operative stage and transfusion in patients undergoing hysterectomy]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc, 2023
Campos-Aguirre E   +2 more
europepmc   +1 more source

Mecanismos de acción de eritropoyetina y eritropoyetina carbamilada en la funcionalidad de células endoteliales

open access: yes, 2018
For a long time, erythropoietin (Epo) was only recognized for its actions in the hematopoietic system. More recently, research aimed at understanding the basic mechanisms of its biological effect has revealed a pleiotropic cytoprotective activity of Epo beyond the regulation of erythropoiesis.
openaire   +3 more sources

Home - About - Disclaimer - Privacy